NCT07584226
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07584226
Title A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Relay Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Los Angeles (UCLA) Department of Medicine RECRUITING Los Angeles California 90095 United States Details
Massachusetts General Hospital RECRUITING Boston Massachusetts 02114 United States Details
START Midwest, LLC RECRUITING Grand Rapids Michigan 49546 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Sarah Cannon Research Institute (SCRI) Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
NEXT Virginia RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field